Got 0 bytes response, method=default Response decode error Got 0 bytes response, method=default Response decode error Reveal G4 | MedMira

Reveal G4

HIV Rapidly Revealed with
MedMira’s Reveal G4

All types of blood specimen - Simple procedure - 
Instant results

The FDA-approved Reveal® G4 is the next generation of rapid testing for HIV using MedMira’s patented Rapid Vertical Flow (RVF) Technology™.

Now able to test fingerstick and venipuncture whole blood, Reveal G4 helps healthcare providers test patients not only in laboratories and hospitals but also in point-of-care settings.

*Reveal G4 test controls are designed for use in customer quality assurance practices, stored at room temperature until ready for use. Each vial is sufficient to perform five Reveal G4 tests.

ALL-IN-ONE SOLUTION AT POINT-OF-CARE

Reveal G4 is the perfect rapid testing solution for any point-of-care setting where only whole blood is readily available:

  • Physicians’ offices & pharmacies
  • Public health programs
  • Voluntary testing and counseling centers
  • Workplace wellness programs
  • Mobile clinics
  • And many, many more

UNRIVALED ACCURACY

Whether testing blood, serum, or plasma, Reveal G4 instantly detects antibodies to HIV-1, and its quality and performance are second to none:

TECHNOLOGY:

Reveal G4 is the latest advanced application of MedMira’s patented Rapid Vertical Flow (RVF) Technology for U.S. customers—allowing for the testing of whole blood specimens in addition to serum and plasma.

This product builds upon the high performance of MedMira’s Reveal product, which enjoyed excellent clinical performance in rigorous evaluations and inspections and consistently ranks as a leading choice in rapid HIV tests for U.S. hospitals.

Additionally, research demonstrates that MedMira’s rapid HIV test detects early infection better than other rapid tests and closely matches the performance of much more complicated enzyme immunoassay tests. Reveal G4 has delivered clinical performance in rigorous evaluations, and achieved approval from the U.S. Food and Drug Administration (FDA) in October of 2015.

Distributed by:

Reveal is approved for clinical laboratory use only in the United States and is distributed by Cardinal Health, VWR International, LLC, and Medline Industries.

Cardinal Health
TF: +1.800.964.5227
www.cardinalhealth.com

VWR International, LLC
TF: +1.800.932.5000
www.vwr.com

Medline Industries
TF: +1.800.633.5463
www.medline.com